Participating Faculty
The American Journal of Managed Care
This supplement to includes information on how bipolar disorder affects quality of life and the impact of misdiagnosis. This program has been peer reviewed by experts in the field.
Faculty
Robert M. A. Hirschfeld, MD
Professor and Chair
University of Texas Medical Branch
Instructor of Psychiatry
Boston, Massachusetts
Lana A. Vornik, MSc
Department of Psychiatry and Behavioral Sciences
Galveston, Texas
Faculty Disclosure
The American Journal of Managed Care
It is the policy of to have all faculty who participate in programs sponsored by pharmaceutical companies disclose any real or apparent conflicts of interest.
These participants report relationships with the following pharmaceutical companies:
Consultant/advisory board member to:
- Abbott Laboratories
- Bristol-Myers Squibb
- Forest Laboratories
- Janssen
- Organon
- Shire
- Wyeth-Ayerst
- Lana A. Vornik, MSc Consultant to: Janssen
Honoraria or consulting fees from:
- Bristol-Myers Squibb
- GlaxoSmithKline Pfizer
The American Journal of Managed Care,
Signed disclosures are on file at the offices of Jamesburg, New Jersey.
This supplement has been supported by funding from AstraZeneca Pharmaceuticals.
---
The contents of this supplement may include information regarding the use of products that may be inconsistent outside the approved labeling for these products in the United States. Physicians should note that the use of these products outside current approved labeling is considered experimental and are advised to consult prescribing information for these products.
Articles in this issue
almost 20 years ago
Article
Bipolar Disorder: Quality of Life and the Impact of Atypical AntipsychoticsNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Related Articles
- Overcoming Weight Bias in Health Care Systems
September 15th 2025